ZEUS And Lp(a)HORIZON: Biomarkers Vs. Cardiovascular Outcomes

Two major cardiovascular trials, ZEUS and Lp(a)HORIZON, demonstrated that successfully altering a biological marker doesn’t guarantee improved patient outcomes.

Back To School, Back To Square One? Vaccine Crisis Tests A Generation

America’s back-to-school season faces a critical challenge as crowded classrooms, waning immunity, & rising vaccine exemptions increase the risk of preventable diseases.

Breakthrough Pancreatic Cancer Drug Might Also Work In Lung Cancer

New trial results indicate that the targeted cancer drug Daraxonrasib might also be beneficial for some patients with lung cancer.

Breakthrough Pancreatic Cancer Drug Shows Promise In Lung Cancer Trial

New trial results indicate that the targeted cancer drug Daraxonrasib might also be beneficial for some patients with lung cancer.

House Like Senate Votes To Delay New Trump OMB Rule Until December 11

On Tuesday, the House, like the Senate had done a month ago, voted for a continuing resolution that would delay the new White House OMB rule until at least December 11.

Pig Kidneys Yield ‘Life-Changing’ Independence From Dialysis

More success for genetically engineered pig kidney transplants. Scientists might have found dark matter. Why space technologies and AI are converging. All that and more in this week’s Prototype.

Michael J. Fox And Harrison Ford Team Up For New Parkinson’s Disease PSA

Harrison Ford and Michael J. Fox teamed up with the help of Ryan Reynolds’ Maximum Effort to film a new PSA for The Michael J. Fox Foundation for Parkinson’s Research.

Pancreatic Cancer Drug Rasonque’s Price Indicates Sustainability Issue

Thinking about the future, it’s inevitable that other cancer drugs like Rasonque will launch at similar or even higher prices. In the long run, how sustainable is this?

Flu And COVID Vaccines This Season — Here’s Who Needs Them, And When

Flu and COVID vaccines were both reformulated for 2026-2027. Here advice from a doctor regarding who should get them and why, and the timing that maximizes protection.

Here Are The Cheapest Ways To Get GLP-1 Drugs In 2026

One in eight US adults takes a GLP-1. Almost none pay list price. Here’s what every way to get the drugs actually costs in 2026, from $25 copays to $1,349 retail.